ShopSpell

Vaccine Adjuvants Methods and Protocols [Paperback]

$92.99     $129.99    28% Off      (Free Shipping)
100 available
  • Category: Books (Medical)
  • ISBN-10:  1493982028
  • ISBN-10:  1493982028
  • ISBN-13:  9781493982028
  • ISBN-13:  9781493982028
  • Publisher:  Humana
  • Publisher:  Humana
  • Binding:  Paperback
  • Binding:  Paperback
  • Pub Date:  01-Jan-2018
  • Pub Date:  01-Jan-2018
  • SKU:  1493982028-11-SPRI
  • SKU:  1493982028-11-SPRI
  • Item ID: 102433589
  • List Price: $129.99
  • Seller: ShopSpell
  • Ships in: 5 business days
  • Transit time: Up to 5 business days
  • Delivery by: Jul 06 to Jul 08
  • Notes: Brand New Book. Order Now.
This collection seeks to elucidate the practical methods necessary for successful adjuvant development, with a particular focus on the synthesis, formulation, manufacturing, and characterization aspects involved. Beginning with an overview and a case study, the book then delves into in silico design, chemical synthesis, biosynthesis, and/or purification from natural raw materials of specific adjuvant molecules, adjuvant formulation approaches, the analytical characterization of adjuvant formulations and adjuvant-containing vaccines, as well as the biological characterization of vaccine adjuvant activity, including in vitro and in vivo approaches, to measure innate and adaptive immune responses. Written in the highly successful Methods in Molecular Biology format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls.

Practical and authoritative, Vaccine Adjuvants: Methods and Protocols aims to facilitate vaccine adjuvant product development efforts, making them more accessible, manufacturable, and better characterized.

1. Overview of Vaccine Adjuvants: Introduction, History, and Current Status

            Ruchi R. Shah, Kimberly J. Hassett, and Luis A. Brito

2. Development of the CpG Adjuvant 1018: A Case Study

            John D. Campbell

3. Syntheses of Human TLR8-Specific Small-Molecule Agonists

     lc§

Add Review